JAMA research shows nearly four in ten American adults live with clustered heart risk factors, with older adults most affected
Washington, D.C., United States, 15...
Exclusive press program selection highlights growing patient access to one-time treatments for sickle cell disease and transfusion-dependent thalassemia.
Somerville, Massachusetts, 4 December 2025 – Genetix...
The move strengthens AstraZeneca’s global market presence, giving the pharma giant greater access to U.S. investors and deeper capital resources.
LONDON — November 3, 2025....
The merger brings together two trusted giants—Kimberly-Clark and Kenvue to redefine the future of personal care and consumer health worldwide
DALLAS — November 3, 2025....
Empowering communities across the U.S. with equal access to life-saving heart health services
RAHWAY, N.J. — November 4, 2025. Heart disease remains the leading cause...
